Trade PULM anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Pulmatrix, Inc. (PULM) is trading at US$1.39, up 2.21% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$5.46M. Over the past 52 weeks, PULM has traded between US$1.16 and US$5.50. On Syfe you can trade PULM with $0 commission and add it to your watchlist.
| Previous close | US$1.36 |
|---|---|
| Market cap | US$5.46M |
| 52-week range | US$1.16 – US$5.50 |
| Volume | 20.17K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Pulmatrix, Inc.
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. in April 2003 and is headquartered in Framingham, MA.
Year: 2014
Pulmatrix, Inc. (PULM) stock is trading at US$1.39, +2.21% from the previous close of US$1.36.
The market cap for Pulmatrix, Inc. (PULM) stock is approximately US$5.46M.
The 52-week high for Pulmatrix, Inc. (PULM) stock is US$5.50.
The 52-week low for Pulmatrix, Inc. (PULM) stock is US$1.16.
Pulmatrix, Inc. (PULM) does not currently pay a dividend.
Stay on top of PULM
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
